Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity

Molecular Biology of the Cell

Volumn 26, Issue 23, 2015, Pages 4209-4223

  Ma, Gary S ^a   Lopez Sanchez, Inmaculada ^a   Aznar, Nicolas ^a   Kalogriopoulos, Nicholas ^a   Pedram, Shabnam ^a   Midde, Krishna ^a   Ciaraldi, Theodore P ^c   Henry, Robert R ^c   Ghosh, Pradipta ^a,b,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; G ALPHA INTERACTING VESICLE ASSOCIATED PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN SENSITIZING AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C THETA; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CCDC88A PROTEIN, HUMAN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN; PROTEIN TYROSINE KINASE; VESICULAR TRANSPORT PROTEIN;

ARTICLE; GLUCOSE TRANSPORT; HUMAN; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; METABOLIC DISORDER; MYOTUBE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; SKELETAL MUSCLE; CELL CULTURE; FEMALE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

CELLS, CULTURED; FATTY ACIDS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN REGULATORS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MICROFILAMENT PROTEINS; MUSCLE, SKELETAL; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; VESICULAR TRANSPORT PROTEINS;

EID: 84947080437     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E15-08-0553     Document Type: Article

References (81)

1. Altiok S, Xu M, Spiegelman BM (1997). PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev 11, 1987-1998.
2. Anderson K, Fitzgerald M, Dupont M, Wang T, Paz N, Dorsch M, Healy A, Xu Y, Ocain T, Schopf L, et al. (2006). Mice deficient in PKC theta demonstrate impaired in vivo T cell activation and protection from T cell-mediated inflammatory diseases. Autoimmunity 39, 469-478.
3. Aroda VR, Ciaraldi T P, Burke P, Mudaliar S, Clopton P, Phillips S, Chang RJ, Henry RR (2009). Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab 94, 469-476.
4. Bai L, Wang Y, Fan J, Chen Y, Ji W, Qu A, Xu P, James DE, Xu T (2007). Dissecting multiple steps of GLUT4 trafficking and identifying the sites of insulin action. Cell Metab 5, 47-57.
5. Beas AO, Taupin V, Teodorof C, Nguyen LT, Garcia-Marcos M, Farquhar MG (2012). Gαs promotes EEA1 endosome maturation and shuts down proliferative signaling through interaction with GIV (Girdin). Mol Biol Cell 23, 4623-4634.
6. Carter AM (2005). Inflammation, thrombosis and acute coronary syndromes. Diabetes Vasc Dis Res 2, 113-121.
7. Chen JF, Guo JH, Moxham CM, Wang HY, Malbon CC (1997). Conditional, tissue-specific expression of Q205L Gαi2 in vivo mimics insulin action. J Mol Med (Berl) 75, 283-289.
8. Cho DH, Choi YJ, Jo SA, Ryou J, Kim JY, Chung J, Jo I (2006). Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition. Am J Physiol Cell Physiol 291, C317-C326.
9. Ciaraldi T P, Maisel A (1989). Role of guanine nucleotide regulatory proteins in insulin stimulation of glucose transport in rat adipocytes. Influence of bacterial toxins. Biochem J 264, 389-396.
10. Dunkel Y, Ong A, Notani D, Mittal Y, Lam M, Mi X, Ghosh P (2012). STAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis. J Biol Chem 287, 41667-41683.
11. Eck MJ, Dhe-Paganon S, Trub T, Nolte RT, Shoelson SE (1996). Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85, 695-705.
12. Enomoto A, Murakami H, Asai N, Morone N, Watanabe T, Kawai K, Murakumo Y, Usukura J, Kaibuchi K, Takahashi M (2005). Akt/PKB regulates actin organization and cell motility via Girdin/APE. Dev Cell 9, 389-402.
13. Fleming I, MacKenzie SJ, Vernon RG, Anderson NG, Houslay MD, Kilgour E (1998). Protein kinase C isoforms play differential roles in the regulation of adipocyte differentiation. Biochem J 333, 719-727.
14. Flores-Riveros JR, Sibley E, Kastelic T, Lane MD (1989). Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit. J Biol Chem 264, 21557-21572.
15. Garcia-Marcos M, Ear J, Farquhar MG, Ghosh P (2011). A GDI (AGS3) and a GEF (GIV) regulate autophagy by balancing G protein activity and growth factor signals. Mol Biol Cell 22, 673-686.
16. Garcia-Marcos M, Ghosh P, Ear J, Farquhar MG (2010). A structural determinant that renders G alpha (i) sensitive to activation by GIV/girdin is required to promote cell migration. J Biol Chem 285, 12765-12777.
17. Garcia-Marcos M, Ghosh P, Farquhar MG (2009). GIV is a nonreceptor GEF for Gαi with a unique motif that regulates Akt signaling. Proc Natl Acad Sci USA 106, 3178-3183.
18. Garcia-Marcos M, Ghosh P, Farquhar MG (2015). GIV/Girdin transmits signals from multiple receptors by triggering trimeric G protein activation. J Biol Chem 290, 6697-6704.
19. Ghosh P, Beas AO, Bornheimer SJ, Garcia-Marcos M, Forry EP, Johannson C, Ear J, Jung BH, Cabrera B, Carethers JM, Farquhar MG (2010). A Gαi-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate. Mol Biol Cell 21, 2338-2354.
20. Ghosh P, Garcia-Marcos M, Bornheimer SJ, Farquhar MG (2008). Activation of Gαi3 triggers cell migration via regulation of GIV. J Cell Biol 182, 381-393.
21. Gohla A, Klement K, Nurnberg B (2007). The heterotrimeric G protein G (i3) regulates hepatic autophagy downstream of the insulin receptor. Autophagy 3, 393-395.
22. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL (1995). Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95, 2195-2204.
23. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI (1999). Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48, 1270-1274.
24. Haasch D, Berg C, Clampit JE, Pederson T, Frost L, Kroeger P, Rondinone CM (2006). PKCθ is a key player in the development of insulin resistance. Biochem Biophys Res Commun 343, 361-368.
25. Hartung A, Ordelheide AM, Staiger H, Melzer M, Haring HU, Lammers R (2013). The Akt substrate Girdin is a regulator of insulin signaling in myoblast cells. Biochim Biophys Acta 1833, 2803-2811.
26. Hoehn KL, Hohnen-Behrens C, Cederberg A, Wu LE, Turner N, Yuasa T, Ebina Y, James DE (2008). IRS1-independent defects define major nodes of insulin resistance. Cell Metab 7, 421-433.
27. Huang B, Babcock H, Zhuang X (2010). Breaking the diffraction barrier: super-resolution imaging of cells. Cell 143, 1047-1058.
28. Hwang H, Bowen B P, Lefort N, Flynn CR, De Filippis EA, Roberts C, Smoke CC, Meyer C, Hojlund K, Yi Z, Mandarino LJ (2010). Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 59, 33-42.
29. Imamura T, Vollenweider P, Egawa K, Clodi M, Ishibashi K, Nakashima N, Ugi S, Adams JW, Brown JH, Olefsky JM (1999). G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol Cell Biol 19, 6765-6774.
30. Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL (2000). Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 49, 1353-1358.
31. Kahn BB, Flier JS (2000). Obesity and insulin resistance. J Clin Invest 106, 473-481.
32. Kanoh Y, Ishizuka T, Morita H, Ishizawa M, Miura A, Kajita K, Kimura M, Suzuki T, Sakuma H, Yasuda K (2000). Effect of pertussis toxin on insulininduced signal transduction in rat adipocytes and soleus muscles. Cell Signal 12, 223-232.
33. Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, Kim DW, Liu ZX, Soos TJ, Cline GW, O'Brien WR, et al. (2004). PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest 114, 823-827.
34. Knowlden JM, Jones HE, Barrow D, Gee JM, Nicholson RI, Hutcheson IR (2008). Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ("Iressa") response and resistance. Breast Cancer Res Treat 111, 79-91.
35. Kreuzer J, Nurnberg B, Krieger-Brauer HI (2004). Ligand-dependent autophosphorylation of the insulin receptor is positively regulated by Gi-proteins. Biochem J 380, 831-836.
36. Krook A, Moller DE, Dib K, O'Rahilly S (1996). Two naturally occurring mutant insulin receptors phosphorylate insulin receptor substrate-1 (IRS-1) but fail to mediate the biological effects of insulin. Evidence that IRS-1 phosphorylation is not sufficient for normal insulin action. J Biol Chem 271, 7134-7140.
37. Krupinski J, Rajaram R, Lakonishok M, Benovic JL, Cerione RA (1988). Insulin-dependent phosphorylation of GTP-binding proteins in phospholipid vesicles. J Biol Chem 263, 12333-12341.
38. Lansey MN, Walker NN, Hargett SR, Stevens JR, Keller SR (2012). Deletion of Rab GAP AS160 modifies glucose uptake and GLUT4 translocation in primary skeletal muscles and adipocytes and impairs glucose homeostasis. Am J Physiol Endocrinol Metabol 303, E1273-E1286.
39. Le-Niculescu H, Niesman I, Fischer T, DeVries L, Farquhar MG (2005). Identification and characterization of GIV, a novel Galpha i/s-interacting protein found on COPI, endoplasmic reticulum-Golgi transport vesicles. J Biol Chem 280, 22012-22020.
40. Le Roith D, Zick Y (2001). Recent advances in our understanding of insulin action and insulin resistance. Diabetes Care 24, 588-597.
41. Leto D, Saltiel AR (2012). Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol 13, 383-396.
42. Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, Littman DR, Birnbaum MJ, Polakiewicz RD (2004). Protein kinase C theta inhibits insulin signaling by phosphorylating IRS1 at Ser (1101). J Biol Chem 279, 45304-45307.
43. Lin C, Ear J, Midde K, Lopez-Sanchez I, Aznar N, Garcia-Marcos M, Kufareva I, Abagyan R, Ghosh P (2014). Structural basis for activation of trimeric Gi proteins by multiple growth factor receptors via GIV/Girdin. Mol Biol Cell 25, 3654-3671.
44. Lin C, Ear J, Pavlova Y, Mittal Y, Kufareva I, Ghassemian M, Abagyan R, Garcia-Marcos M, Ghosh P (2011). Tyrosine phosphorylation of the Gα-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration. Sci Signal 4, ra64.
45. Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC (2000). Protein kinase C-8 participates in NF-kB activation induced by CD3-CD28 costimulation through selective activation of IκB kinase (3. Mol Cell Biol 20, 2933-2940.
46. Lo IC, Gupta V, Midde KK, Taupin V, Lopez-Sanchez I, Kufareva I, Abagyan R, Randazzo PA, Farquhar MG, Ghosh P (2015). Activation of Gαi at the Golgi by GIV/Girdin imposes finiteness in Arf1 signaling. Dev Cell 33, 189-203.
47. Lopez-Sanchez I, Dunkel Y, Roh YS, Mittal Y, De Minicis S, Muranyi A, Singh S, Shanmugam K, Aroonsakool N, Murray F, et al. (2014). GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis. Nat Commun 5, 4451.
48. Lopez-Sanchez I, Garcia-Marcos M, Mittal Y, Aznar N, Farquhar MG, Ghosh P (2013). Protein kinase C-theta (PKCtheta) phosphorylates and inhibits the guanine exchange factor, GIV/Girdin. Proc Natl Acad Sci USA 110, 5510-5515.
49. Ma GS, Aznar N, Kalogriopoulos N, Midde KK, Lopez-Sanchez I, Sato E, Dunkel Y, Gallo RL, Ghosh P (2015). Therapeutic effects of cell-permeant peptides that activate G proteins downstream of growth factors. Proc Natl Acad Sci USA 112, E2602-E2610.
50. Maegawa H, Shigeta Y, Egawa K, Kobayashi M (1991). Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 40, 815-819.
51. Markova I, Zidek V, Musilova A, Simakova M, Mlejnek P, Kazdova L, Pravenec M (2010). Long-term pioglitazone treatment augments insulin sensitivity and PKC-epsilon and PKC-theta activation in skeletal muscles in sucrose fed rats. Physiol Res 59, 509-516.
52. Mashili F, Chibalin AV, Krook A, Zierath JR (2013). Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Diabetes 62, 457-465.
53. Midde KK, Aznar N, Laederich MB, Ma GS, Kunkel MT, Newton AC, Ghosh P (2015). Multimodular biosensors reveal a novel platform for activation of G proteins by growth factor receptors. Proc Natl Acad Sci USA 112, E937-E946.
54. Miinea CP, Sano H, Kane S, Sano E, Fukuda M, Peranen J, Lane WS, Lienhard GE (2005). AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain. Biochem J 391, 87-93.
55. 2. Nature 379, 840-844.
56. Myers MG Jr, Grammer TC, Brooks J, Glasheen EM, Wang LM, Sun XJ, Blenis J, Pierce JH, White MF (1995). The pleckstrin homology domain in insulin receptor substrate-1 sensitizes insulin signaling. J Biol Chem 270, 11715-11718.
57. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM (1994). Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 78, 471-477.
58. O'Brien RM, Houslay MD, Milligan G, Siddle K (1987). The insulin receptor tyrosyl kinase phosphorylates holomeric forms of the guanine nucleotide regulatory proteins Gi and Go. FEBS Lett 212, 281-288.
59. Pessin JE, Saltiel AR (2000). Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106, 165-169.
60. Pugazhenthi S, Khandelwal RL (1998). Insulin action on protein phosphatase-1 activation is enhanced by the antidiabetic agent pioglitazone in cultured diabetic hepatocytes. Mol Cell Biochem 182, 185-191.
61. Rothenberg PL, Kahn CR (1988). Insulin inhibits pertussis toxin-catalyzed ADP-ribosylation of G-proteins. Evidence for a novel interaction between insulin receptors and G-proteins. J Biol Chem 263, 15546-15552.
62. Rundek T, Gardener H, Xu Q, Goldberg RB, Wright CB, Boden-Albala B, Disla N, Paik MC, Elkind MS, Sacco RL (2010). Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol 67, 1195-1200.
63. Saltiel AR, Kahn CR (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806.
64. Sato M, Ozawa T, Inukai K, Asano T, Umezawa Y (2002). Fluorescent indicators for imaging protein phosphorylation in single living cells. Nat Biotechnol 20, 287-294.
65. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, Biden TJ (1997). Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46, 169-178.
66. Sharma C, Pradeep A, Pestell RG, Rana B (2004). Peroxisome proliferatoractivated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes. J Biol Chem 279, 16927-16938.
67. Shulman GI (2000). Cellular mechanisms of insulin resistance. J Clin Invest 106, 171-176.
68. Song X, Zheng X, Malbon CC, Wang H (2001). Gαi2 enhances in vivo activation of and insulin signaling to GLUT4. J Biol Chem 276, 34651-34658.
69. Stockli J, Fazakerley DJ, James DE (2011). GLUT4 exocytosis. J Cell Sci 124, 4147-4159.
70. Sun Y, Bilan PJ, Liu Z, Klip A (2010). Rab8A and Rab13 are activated by insulin and regulate GLUT4 translocation in muscle cells. Proc Natl Acad Sci USA 107, 19909-19914.
71. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF (1991). Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352, 73-77.
72. Taniguchi CM, Emanuelli B, Kahn CR (2006). Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7, 85-96.
73. Thorburn AW, Gumbiner B, Bulacan F, Wallace P, Henry RR (1990). Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. J Clin Invest 85, 522-529.
74. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, et al. (2010). Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28, 1248-1250.
75. Voliovitch H, Schindler DG, Hadari YR, Taylor SI, Accili D, Zick Y (1995). Tyrosine phosphorylation of insulin receptor substrate-1 in vivo depends upon the presence of its pleckstrin homology region. J Biol Chem 270, 18083-18087.
76. Weng L, Enomoto A, Miyoshi H, Takahashi K, Asai N, Morone N, Jiang P, An J, Kato T, Kuroda K, et al. (2014). Regulation of cargo-selective endocytosis by dynamin 2 GTPase-activating protein girdin. EMBO J 33, 2098-2112.
77. White MF (2006). Regulating insulin signaling and beta-cell function through IRS proteins. Canadian J Physiol Pharmacol 84, 725-737.
78. White M F, Shoelson SE, Keutmann H, Kahn CR (1988). A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 263, 2969-2980.
79. Wunderlich CM, Hovelmeyer N, Wunderlich FT (2013). Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. Jak-Stat 2, e23878.
80. Yamamoto N, Sato T, Kawasaki K, Murosaki S, Yamamoto Y (2006). A nonradioisotope, enzymatic assay for 2-deoxyglucose uptake in L6 skeletal muscle cells cultured in a 96-well microplate. Analytical Biochem 351, 139-145.
81. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, et al. (2002). Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277, 50230-50236.